[Edaily Reporter NA EUN-KYUNG ] CHONGKUNDANG(185750)announced on the 24th that it will host the final round of the amateur futsal tournament, the “Kefem Air Spray Challenge Match,” at Times Square in Yeongdeungpo, Seoul, on the 27th.
(Source: CHONGKUNDANG)
This tournament was organized by CHONGKUNDANG as part of its official partnership with the Korea Football Association (KFA). Ahead of the 2026 North and Central America World Cup, it was designed as an experiential program open to soccer enthusiasts and the general public.
CHONGKUNDANG recruited participating teams from amateur soccer enthusiasts nationwide last April and held regional qualifying rounds starting in May. A total of 39 teams participated, and six of them advanced to the finals.
The event venue will feature a futsal court as well as a KEPEM brand experience zone. Events featuring former national soccer team player and coach Choi Jin-chul, along with programs for spectators, are also scheduled to take place.
Kefem Air Spray is a nonsteroidal anti-inflammatory drug (NSAID) containing ketoprofen; it is an over-the-counter medication used to relieve pain and inflammation caused by arthritis, muscle pain, tendinitis, and bruises. It is characterized by its spray formulation, which allows it to be applied directly to the affected area.
Since signing an official partnership with the Korea Football Association last year, CHONGKUNDANG has been conducting marketing initiatives in conjunction with the national soccer team. The company explained that this event is also part of its efforts to raise brand awareness at sporting events and expand consumer touchpoints.
CHONGKUNDANG official stated, “Kefem is a product designed to help users actively manage pain rather than simply endure it, enabling them to achieve peak performance,” adding, “We plan to continue various programs that allow us to engage with consumers at sporting events.”
(Photo: Blind)
One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…